Perfromance Wealth Partners, LLC Bio N Tech Se Transaction History
Perfromance Wealth Partners, LLC
- $2.89 Billion
- Q3 2024
A detailed history of Perfromance Wealth Partners, LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Perfromance Wealth Partners, LLC holds 2,000 shares of BNTX stock, worth $228,940. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,000Holding current value
$228,940% of portfolio
0.01%Shares
2 transactions
Others Institutions Holding BNTX
# of Institutions
323Shares Held
38.7MCall Options Held
845KPut Options Held
1.23M-
Baillie Gifford & CO8.28MShares$947 Million0.53% of portfolio
-
Primecap Management CO Pasadena, CA4.79MShares$548 Million0.28% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.38MShares$501 Million1.49% of portfolio
-
Harding Loevner LP Bridgewater, NJ2.93MShares$335 Million1.34% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$217 Million0.0% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $27.8B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...